Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00105274

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:31.441632+00:00

Published At

2017-07-02T00:00:00+00:00

Record Updated At

2017-07-02

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["DiGeorge Syndrome", "Velocardiofacial Syndrome", "22q11.2 Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2017-07-02"

protocolSection.identificationModule.nctId

"NCT00105274"

protocolSection.identificationModule.officialTitle

"Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• DiGeorge Syndrome (protocolSection.conditionsModule.conditions)
• Velocardiofacial Syndrome (protocolSection.conditionsModule.conditions)
• 22q11.2 Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.